Tag: EQ-5D

MAPPING THE CLINICAL COPD QUESTIONNAIRE ONTO EQ-5D VALUES

Rotterdam, The Netherlands – The Clinical COPD Questionnaire (CCQ) is a widely-used questionnaire to assess the effectiveness of chronic obstructive pulmonary disease (COPD) treatments. However, it is not a preference-based measure, and hence cannot be directly used to estimate the

Posted in Announcements, Methodological Articles, Value in Health Tagged with: , , , , , , ,

WHAT IS THE IMPACT OF ADDING EXTRA HEALTH DIMENSIONS TO THE EQ-5D?

Oxford, UK  –  Generic preference-based measures of health are commonly used to evaluate the impact of diseases and their treatments on overall health related quality of life by weighting their dimensions using people’s value judgements. However, these measures, including the

Posted in Preference-Based Assessments, Value in Health Tagged with: , , , , , ,

Potential Common Benchmark For Assessing New Diabetes Treatments

Basel, Switzerland – Many new products for type 2 diabetes mellitus (T2DM) will be launched in the coming years as a response to this ever-increasing world epidemic. Health technology assessment (HTA) agencies require cost-effectiveness studies of these agents, but no consistent

Posted in Systematic Reviews, Value in Health Tagged with: , , , ,

Quality Of Life In Heart Patients: The Way You Measure Drives The Results

Gent, Belgium – Pain, anxiety, and functional or social limitations can cause an impaired Health-Related Quality of Life (HRQoL) in heart patients. Several measures exist to assess HRQoL, with some of them, such as the EQ-5D and the SF-6D (derived from

Posted in Preference-Based Assessments, Value in Health Tagged with: , , , ,